Related Experiment Videos
Retinopathy of prematurity
1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida.
Insights
Retinopathy of prematurity (ROP) is a significant infant eye disease. Understanding ROP offers insights into other blinding vascular retinopathies and improves care for premature infants.
Area of Science:
- Ophthalmology
- Neonatology
- Vascular Biology
Background:
- Retinopathy of prematurity (ROP) presented significant challenges in the 1980s.
- Understanding ROP can inform research into other blinding vascular retinopathies like diabetic and sickle cell retinopathy.
Purpose of the Study:
- To delineate the scope of ROP as a disease.
- To present a theory on ROP's development and progression.
- To review key issues for pediatric, ophthalmologic, and basic science communities.
Main Methods:
- Review of existing studies, including those in progress or planning stages.
- Synthesis of information on oxygen, ventilation, antioxidants, and blood transfusions in premature infants.
- Exploration of ROP's relationship with other infant diseases.
Main Results:
- The article outlines the multifaceted nature of ROP.
- It proposes a theoretical framework for ROP's pathogenesis.
- It highlights ongoing research and future directions.
Conclusions:
- Further research into ROP is crucial for advancing care in neonatology and ophthalmology.
- Clarifying the roles of various medical interventions will enhance treatment strategies for premature infants.
- Addressing ROP provides a model for understanding and managing other vascular retinopathies.
Abstract:
ROP is a challenging disease of the decade of the 1980s. Answers, even partial answers, to many of its questions may provide information bearing on those same questions in other blinding vascular retinopathies, such as diabetes and sickle cell disease. Answers more clearly defining the role of oxygen, ventilation, antioxidants, blood transfusions, and a host of diseases of the premature infant will lead to better care of that infant. I have tried in this article to present the boundaries of the problem, a theory of its genesis and progression, and a review of the major issues to be confronted by the pediatric, ophthalmologic, and basic science communities through its recurrence today. I have tried to make it clear to the reader when I was so doing. I have used information liberally from studies both under way and in the planning stages to make the reader aware of what is being done, even if these have not yet reached fruition, for the field is a rapidly growing one. Finally, I have tried to point out directions that I believe clinical and experimental work should take on certain critical issues.